HMGB1 and metabolic disease: While HMGB1 is a well-known marker of inflammation, increased expression of HMGB1, associated with its promoter DNA’s methylation alteration, was reported in cardiac progenitor cells following hypoxia and metabolic diseases [79,80], suggesting that DNA methylation is a mechanism for HMGB1 regulation.